OMX Copenhagen PI
1 449,27
|
-34,80
|
-2,34%
|
Analysen zu OMX Copenhagen PI-Werten
10.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
09.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
09.08.23 | Novo Nordisk Sell | UBS AG | |
08.08.23 | Novo Nordisk Overweight | Barclays Capital | |
08.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
08.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
07.08.23 | A.P. Moeller - Maersk A-S Overweight | JP Morgan Chase & Co. | |
07.08.23 | A.P. Moeller - Maersk A-S Sell | Goldman Sachs Group Inc. | |
03.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
27.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
13.07.23 | A.P. Moeller - Maersk A-S Buy | UBS AG | |
12.07.23 | Novo Nordisk Sell | UBS AG | |
12.07.23 | Novo Nordisk Buy | Deutsche Bank AG | |
11.07.23 | Novo Nordisk Outperform | Credit Suisse Group | |
05.07.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
28.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
27.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
27.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
26.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
26.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
26.06.23 | Novo Nordisk Sell | UBS AG | |
20.06.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
19.06.23 | Novo Nordisk Sell | UBS AG | |
15.06.23 | A.P. Moeller - Maersk A-S Overweight | JP Morgan Chase & Co. | |
12.06.23 | Novo Nordisk Sell | UBS AG | |
08.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
26.05.23 | Novo Nordisk Sell | UBS AG | |
23.05.23 | Novo Nordisk Overweight | Barclays Capital | |
23.05.23 | Novo Nordisk Buy | Deutsche Bank AG | |
22.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
22.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
08.05.23 | A.P. Moeller - Maersk A-S Neutral | UBS AG | |
05.05.23 | Novo Nordisk Buy | Deutsche Bank AG | |
05.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.05.23 | A.P. Moeller - Maersk A-S Overweight | JP Morgan Chase & Co. | |
05.05.23 | Novo Nordisk Outperform | Credit Suisse Group | |
04.05.23 | Novo Nordisk Sell | UBS AG |